News & Press Releases

Law360 featured commentary from Jason P.W. Halperin in an article about a pharmaceutical industry insider trading case brought by the DOJ. Jason and Elizabeth Platonova represented one of the defendants and negotiated a resolution in which he pled guilty and was sentenced to 15 months in prison.

Mintz advised the placement agents in connection with CAMP4's up to $100 million private placement.  The private placement included upfront gross proceeds of $50 million in exchange for common stock (and pre-funded warrants in lieu of common stock for certain investors). In addition, CAMP4 will be eligible to receive up to an additional $50 million in gross proceeds in exchange for common stock (and pre-funded warrants for certain investors), subject to achieving pre-specified milestones, including receipt of regulatory clearance to initiate a Phase 1/2 clinical trial in SYNGAP patients with its development candidate, CMP-SYNGAP-01.

The Deal quoted Member Theresa Carnegie in a recent article about how regulatory pressure on pharmacy benefit managers (PBMs) has sparked innovation and opened up investment opportunities in the industry. Increased scrutiny of larger PBMs over concerns about competition and drug prices has prompted newer PBMs to emphasize transparency.

Mintz members Daniel Guggenheim, Rebecca Lee, and Jeffrey Moerdler have been recognized by Lawdragon in its 2025 500 Leading Global Real Estate Lawyers list. The three attorneys were also recognized in last year’s inaugural edition of the list.

Mintz advised the underwriters in connection with the $230 million underwritten offering by Ondas Holdings Inc. of 46,000,000 shares of its common stock, which includes 6,000,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.

Mintz advised Andromeda Robotics on its AU$23 million Series A capital raise, led by San Francisco’s Forerunner Ventures.